Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma

Key Points

Key points are not available for this paper at this time.

Abstract

Bypass resistance may be the most frequent mechanism of progression under RETi. A more aggressive histology may arise following RETi and warrants further investigation.

Bookmark

Cite This Study

Hadoux et al. (Fri,) studied this question.

synapsesocial.com/papers/69d76fcc5f9a1dad534902a7 https://doi.org/https://doi.org/10.1200/po.23.00053

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The repertoire of mutational signatures in human cancer2020 · 3,719 citations
2International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid Carcinoma2021 · 135 citations
3A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations2020 · 102 citations
4Rare thyroid malignancies in Europe: Data from the information network on rare cancers in Europe (RARECAREnet)2020 · 10 citations
5Liquid Biopsies for Circulating Tumor DNA Detection May Reveal Occult Hematologic Malignancies in Patients With Solid Tumors2023 · 20 citations